Interesting. The one advantage the test give I was guessing, is looking at the failures for 700mg and elimination many of them, giving a higher success rate. So, my guess is if they are not concerned with fda approval based on the data now at 700mg then they will go for it without the test. I doubt the results are back yet, so I'm guessing this submission next week will be without this test.